🔗 bit.ly/46kajHr
@simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social
🔗 bit.ly/46kajHr
@simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social
The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik.
Follow us for more!
@martinhoenigl.bsky.social @agocarvalho.bsky.social
@simonfeys.bsky.social
The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik.
Follow us for more!
@martinhoenigl.bsky.social @agocarvalho.bsky.social
@simonfeys.bsky.social
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
Join us on Saturday 12/04 in #Vienna 🇦🇹.
👉 RSVP: forms.gle/spTQGnWfjd11...
Join us on Saturday 12/04 in #Vienna 🇦🇹.
👉 RSVP: forms.gle/spTQGnWfjd11...
Now we just need a logo…
🌌Galectin-3 targeted antifungal prophylaxis in ICU influenza (GALActIC)🌌
eppermed.eu project at UZLeuven
Incredibly productive meeting with the Galactic team @agocarvalho.bsky.social @simonfeys.bsky.social @msgerc.bsky.social @ishamycology.bsky.social
Now we just need a logo…
w/ @simonfeys.bsky.social @agocarvalho.bsky.social & cie
Actively working on more answers. Stay tuned.
👉 doi.org/10.1016/j.cm...
w/ @simonfeys.bsky.social @agocarvalho.bsky.social & cie
Actively working on more answers. Stay tuned.
👉 doi.org/10.1016/j.cm...